基于蛋白质组学探讨消癌解毒方调控Nrf2/HMOX1通路促进肝癌细胞铁死亡的作用机制

Proteomics-Based Study on the Mechanism of Xiaoai Jiedu Recipe Regulating Nrf2/HMOX1 Pathway to Promote Ferroptosis in Hepatocellular Carcinoma Cells

  • 摘要:
      目的  通过蛋白质组学方法探讨消癌解毒方促进肝癌小鼠肿瘤细胞铁死亡, 抑制移植瘤生长的作用机制。
      方法  C57BL/6J小鼠随机分为模型组、消癌解毒方低剂量组、消癌解毒方高剂量组、消癌解毒方联合铁死亡抑制剂组、铁死亡抑制剂组、顺铂组。构建H22小鼠移植瘤模型, 消癌解毒方低、高剂量组予消癌解毒方灌胃, 剂量分别为(10、20 g·kg-1·d-1); 铁死亡抑制剂组予Liproxstatin-1腹腔注射, 剂量为10 mg·kg-1·d-1; 顺铂组予顺铂腹腔注射, 剂量为10 mg·kg-1·d-1; 消癌解毒方联合铁死亡抑制剂组予消癌解毒方(20 g·kg-1·d-1)灌胃以及Liproxstatin-1(10 mg·kg-1·d-1)腹腔注射, 模型组灌胃等量生理盐水。连续给药11 d后剥取瘤体计算抑瘤率;HE染色检测病理变化;透射电镜观察线粒体结构变化;流式细胞术检测瘤体组织活性氧(ROS)水平;制备血清以TMT肽段标记结合LC-MS/MS寻找差异蛋白表达谱、应用IPA软件进行分析;生化检测血清铁离子、还原型谷胱甘肽(GSH)及丙二醛(MDA)含量;Western blot法检测核因子E2相关因子2(Nrf2)、血红素加氧酶-1(HMOX1)、胱氨酸/谷氨酸逆向转运蛋白(SLC7A11)和谷胱甘肽过氧化物酶4(GPX4)的蛋白表达水平。
      结果  消癌解毒方低、高剂量及顺铂能抑制瘤体生长, 抑瘤率分别为36.12%、51.63%、57.43%, 铁死亡抑制剂促进了瘤体的生长, 抑瘤率为-45.56%, 消癌解毒方联合铁死亡抑制剂组瘤体较铁死亡抑制剂组缩小, 抑瘤率为18.11%;HE染色显示消癌解毒方高剂量组、顺铂组瘤体组织出现凋亡细胞及大量空泡蓄积; 透射电镜结果显示, 消癌解毒方低、高剂量组出现一定程度的线粒体萎缩及膜密度增加; 流式结果显示: 消癌解毒方干预后ROS水平明显升高(P < 0.01);蛋白质组学检测显示, 消癌解毒方高剂量组与模型组相比差异蛋白共129个, 其中下调蛋白62个, 上调蛋白67个, 差异表达涉及脂质代谢等方面; 生化检测结果显示, 消癌解毒方干预可升高小鼠血清铁离子、MDA含量, 降低GSH含量; Western blot结果显示, 消癌解毒方高剂量组干预后Nrf2、HMOX1蛋白表达水平增高, SLC7A11、GPX4蛋白表达水平降低(P < 0.01)。
      结论  消癌解毒方可调控Nrf2/HMOX1信号通路, 调节氧化应激, 升高脂质过氧化水平, 促进肝癌细胞铁死亡, 可能是其抑制移植瘤生长的作用机制之一。

     

    Abstract:
      OBJECTIVE  To investigate the mechanism of Xiaoai Jiedu Recipe in promoting ferroptosis of tumor cells and inhibiting the growth of transplanted tumors in hepatocellular carcinoma mice by proteomics method.
      METHODS  C57BL/6J mice were randomly divided into, model group, low- and high-dose groups of Xiaoai Jiedu Recipe, Xiaoai Jiedu Recipe combined with ferroptosis inhibitor group, ferroptosis inhibitor group and cisplatin group. The H22 mouse transplantation tumor model was constructed and the drug administration interventions were as follows: the low- and high-dose groups of Xiaoai Jiedu Recipe were given Xiaoai Jiedu Recipe by gavage at the doses of 10 and 20 g·kg-1·d-1; the ferroptosis inhibitor group was given Liproxstatin-1 by intraperitoneal injection at the dose of 10 mg·kg-1·d-1; the cisplatin group was given cisplatin by intraperitoneal injection at the dose of 10 mg·kg-1·d-1; the Xiaoai Jiedu Recipe combined with ferroptosis inhibitor group was given a gavage dose of 20 g·kg-1·d-1of Xiaoai Jiedu Recipe and an intraperitoneal injection of 10 mg·kg-1·d-1 of the ferroptosis inhibitor Liproxstatin-1; the model group was given an equal amount of saline by gavage. The drugs were administered for 11 d continuously. The tumors were stripped to calculate tumor inhibition rate. Pathological changes were observed by hematoxylin-eosin (HE). Mitochondrial structural changes were observed by transmission electron microscopy. Reactive oxygen species (ROS) levels were detected by flow cytometry. Serum was prepared and analysed by TMT peptide labelling combined with LC-MS/MS to find differential protein expression profiles, applying IPA software. Serum iron ions, glutathione (GSH) and malondialdehyde (MDA) levels were measured biochemically. Protein expression levels of nuclear factor E2-related factor 2 (Nrf2), heme oxygenase-1 (HMOX1), cystine/glutamate reverse transporter protein (SLC7A11) and glutathione peroxidase 4 (GPX4) were measured by protein Western blot.
      RESULTS  The tumor growth was inhibited in the low- and high-dose groups and the cisplatin group, with inhibition rates of 36.12%, 51.63% and 57.43%, respectively, while the tumor growth was promoted in the ferroptosis inhibitor group, with an inhibition rate of -45.56%, and the tumor size was reduced in the Xiaoai Jiedu Recipe combined with ferroptosis inhibitor group compared with the ferroptosis inhibitor group, with an inhibition rate of 18.11%. HE staining showed that apoptotic cells and a large number of vacuoles accumulated in the tumor tissues of the high-dose group and the cisplatin group. Transmission electron microscopy showed that the mitochondrial atrophy and membrane density increased to a certain extent in the low and high-dose groups of Xiaoai Jiedu Recipe. Flow cytometry results showed that ROS levels were significantly increased after the intervention of Xiaoai Jiedu Recipe (P < 0.01). Proteomic tests showed that there were 129 differential proteins, including 62 down-regulated proteins and 67 up-regulated proteins, in the high-dose group of Xiaoai Jiedu Recipe compared with the model group, and these differential expressions were involved in lipid metabolism, et al. The results of biochemical tests showed that the intervention of Xiaoai Jiedu Recipe increased the serum iron and MDA levels, and decreased the GSH level in mice. Western blot results showed that the protein expression levels of Nrf2 and HMOX1 increased, and those of SLC7A11 and GPX4 decreased after the intervention of the high-dose group of Xiaoai Jiedu Recipe (P < 0.01).
      CONCLUSION  Xiaoai Jiedu Recipe promotes ferroptosis in hepatocellular carcinoma cells by inducing the Nrf2/HMOX1 signaling pathway, regulating oxidative stress and elevating the level of lipid peroxidation, which may be one of its mechanisms of action in inhibiting the growth of transplanted tumors.

     

/

返回文章
返回